<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 4</issue_number>
<issue_period>2015 (October - December)</issue_period>
<title>VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES OF NOVEL INHIBITORS FOR HIV REVERSE TRANSCRIPTASE </title>
<abstract>Human Immunodeficiency Virus is caused by retrovirus in human beings, where the overall immune system fails resulting in opportunistic infections, HIV-1 Reverse Transcriptase (RT) is an important enzyme supporting replication cycle of HIV. Reverse Transcriptase protein an essential focus in the current medications for HIV-1, because of flexible nature of the target proteins, there is a basic need to find novel, powerful medications against HIV. Henceforth, an endeavor has been made to screen ZINC compound Library, Using e-HiTS software in docking process with nevirapine bound HIV-RT, 884 ligands with alike properties were tested for their binding affinity towards targeted enzyme and at last 39 hits were reported as effective inhibitors of HIV-RT Virus.</abstract>
<authors>Dr. PVRD PRASADA RAO AND Dr.K.RAMAMOHANA RAO</authors>
<keywords>Retrovirus, Nevirapine, Virtual Screening, e-HITS and ZINC database.</keywords>
<pages>1190-1196</pages>
</article>
</Journal>
